Skip to content

Clinical trials

Phase 1 Lupus Erythematosus, Systemic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 1 Country / region: China Clear all

108 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20173
20181
20191
20214
20222
20238
202420
202541
202627

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting58
Not yet recruiting20
Unknown status10
Completed9
Withdrawn4
Active, not recruiting3
Terminated3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology8
The Children's Hospital of Zhejiang University School of Medicine6
China Immunotech (Beijing) Biotechnology Co., Ltd.5
Chongqing Precision Biotech Co., Ltd5
AstraZeneca3
CytoCares Inc3
GlaxoSmithKline3
Nanjing Bioheng Biotech Co., Ltd.3
RenJi Hospital3
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic108
Myositis26
Scleroderma, Systemic26
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis22
Autoimmune Diseases19
Sjogren's Syndrome13
Arthritis, Rheumatoid9
Antiphospholipid Syndrome8
Lupus Nephritis7
Recurrence7

Trials

Showing 1 to 25 of 108. Each trial links to its page on Pharma Observatory.

8 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.